Compare Hims and Hers Health Inc (HIMS) vs Kaltura Inc (KLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Kaltura Inc — how do they compare? Hims and Hers Health Inc trades at $28.44 (market cap $6.55B), while Kaltura Inc trades at $1.32 (market cap $199.08M). The key difference: Hims and Hers Health Inc is far larger — about 32.9× Kaltura Inc's market cap, and Kaltura Inc is more actively traded (175,927 versus 14,842,814). Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Kaltura Inc for 21 Days on average.
| HIMS | KLTR | |
|---|---|---|
Market Cap | $6.55B | $199.08M |
Volume | 14,842,814 | 175,927 |
Sector | Health | Technology |
52-Week High | $62.76 | $1.89 |
52-Week Low | $14.52 | $1.08 |
Typical Hold Time | 21 Days | 21 Days |
Enterprise Value | $7.25B | $211.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.
The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.
KLTR trades at $1.33, up 3.91% today, showing positive momentum despite a bearish technical signal. The company demonstrates improving fundamentals with revenue stabilizing around $181M and net losses narrowing from -$68M in 2022 to -$12M in 2025. Recent earnings beats and industry recognition for AI-powered video platforms provide optimism, though negative ROE (-134.25%) and high debt levels remain concerns.
KLTR presents a turnaround story with improving financials and strong AI positioning, but faces significant execution risks. The stock offers speculative upside if the company can achieve profitability, though current valuation metrics (P/S 1.08, EV/EBITDA 271.59) reflect market skepticism about near-term earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →
